Status:
RECRUITING
The Effect of Sleep Loss on Emotion Regulation
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Sleep
Insomnia
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The study is designed to investigate the impact of three nights of sleep restricted to 4 hours per night, on the processing and regulation of emotional information compared to Insomnia Disorder and co...
Detailed Description
Goal 1: How does sleep loss and clinical sleep disruption (i.e. Insomnia Disorder) impact emotion perception and emotion regulation? The investigators are interested in how chronic loss of sleep, eith...
Eligibility Criteria
Inclusion
- willing and able to follow the protocol
- willing and able to meet inclusion criteria for fMRI scanning
- willing to refrain from alcohol and recreational drugs for the duration of the protocol
- normal or corrected to normal vision is required
Exclusion
- left-handedness or ambidexterity
- the use of any drugs that could affect either sleep or cognitive functioning (e.g., prescription sleeping pills or antidepressants)
Key Trial Info
Start Date :
May 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05393830
Start Date
May 11 2023
End Date
July 31 2027
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215